Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2

NCT04345900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Neutropenia

Interventions

DRUG: Plinabulin
DRUG: Pegfilgrastim

Sponsor

BeyondSpring Pharmaceuticals Inc.